KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Opko Health (OPK) Accumulated Depreciation & Amortization (2016 - 2025)

Opko Health's Accumulated Depreciation & Amortization history spans 15 years, with the latest figure at -$65.2 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 32.61% year-over-year to -$65.2 million; the TTM value through Dec 2025 reached -$65.2 million, down 32.61%, while the annual FY2025 figure was -$65.2 million, 32.61% down from the prior year.
  • Accumulated Depreciation & Amortization reached -$65.2 million in Q4 2025 per OPK's latest filing, down from -$49.2 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $108.7 million in Q4 2022 to a low of -$70.2 million in Q4 2023.
  • Average Accumulated Depreciation & Amortization over 5 years is $16.7 million, with a median of $23.5 million recorded in 2021.
  • Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 171.27% in 2022, then plummeted 164.58% in 2023.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $78.7 million in 2021, then surged by 38.03% to $108.7 million in 2022, then tumbled by 164.58% to -$70.2 million in 2023, then increased by 29.9% to -$49.2 million in 2024, then crashed by 32.61% to -$65.2 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Accumulated Depreciation & Amortization are -$65.2 million (Q4 2025), -$49.2 million (Q4 2024), and -$70.2 million (Q4 2023).